Search results for "Exome"

showing 10 items of 202 documents

Exome sequencing of three cases of familial exceptional longevity

2014

Exceptional longevity (EL) is a rare phenotype that can cluster in families, and co-segregation of genetic variation in these families may point to candidate genes that could contribute to extended lifespan. In this study, for the first time, we have sequenced a total of seven exomes from exceptionally long-lived siblings (probands ≥ 103 years and at least one sibling ≥ 97 years) that come from three separate families. We have focused on rare functional variants (RFVs) which have ≤ 1% minor allele frequency according to databases and that are likely to alter gene product function. Based on this, we have identified one candidate longevity gene carrying RFVs in all three families, APOB. Inter…

Exome sequencingCienciaMaleAgingCandidate genemedia_common.quotation_subjectLongevityEnvejecimientoBiologyGene FrequencyCentenariansGenetic variationapolipoprotein BHumansExomeAllele frequencyGeneExomeExome sequencingmedia_commonGeneticsShort TakesAged 80 and overFamily HealthLongevityrare variantsGenetic VariationRare variantsCell BiologyGenéticaMinor allele frequencyApolipoprotein B-100FemalecentenariansApolipoprotein Bexome sequencingAging Cell
researchProduct

Molecular and patho-physiological basis of syndromes with developmental anomalies and intellectual disability

2013

Intellectual disability (ID) corresponds to abnormal intellectual performances and adaptive functions, beginning in childhood. It is estimated that 2-3% of individuals develop a ID, which represents a significant medical challenge since people with ID are frequently in situations of social dependence. Overall, a critical involvement of genetic factors in this disease is suspected. To date, several hundreds of genes are known to be responsible for ID. The ID is particularly characterized by extreme clinical and genetic heterogeneity, that made it resistant to conventional genetic studies. However, it is classicaly separated between syndromic ID, which may be clinically recognizable due to as…

Exome sequencingMendelian disorders[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyShprintzen-Goldberg syndromeIntellectual disabilitySyndromes microdélétionnels[SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human geneticsAnomalies du développementDéficience intellectuelleSéquençage d’exomeMicrodeletionnal syndromesSyndrome de Shprintzen-Goldberg[SDV.BDD] Life Sciences [q-bio]/Development BiologyMultiple congenital anomalies[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologyMaladies mendéliennes
researchProduct

Confidence-based Somatic Mutation Evaluation and Prioritization

2012

Next generation sequencing (NGS) has enabled high throughput discovery of somatic mutations. Detection depends on experimental design, lab platforms, parameters and analysis algorithms. However, NGS-based somatic mutation detection is prone to erroneous calls, with reported validation rates near 54% and congruence between algorithms less than 50%. Here, we developed an algorithm to assign a single statistic, a false discovery rate (FDR), to each somatic mutation identified by NGS. This FDR confidence value accurately discriminates true mutations from erroneous calls. Using sequencing data generated from triplicate exome profiling of C57BL/6 mice and B16-F10 melanoma cells, we used the exist…

False discovery rateSequence analysisSomatic cellQH301-705.5Low ConfidenceDNA Mutational AnalysisBiologySensitivity and SpecificityDNA sequencing03 medical and health sciencesCellular and Molecular NeuroscienceMice0302 clinical medicineGermline mutationGenetic MutationGeneticsAnimalsExomeFalse Positive ReactionsGenome SequencingBiology (General)Molecular BiologyExomeBiologyMelanomaEcology Evolution Behavior and SystematicsHealth aging / healthy living Cardiovascular diseases [IGMD 5]030304 developmental biologyGenetics0303 health sciencesEcologyReceiver operating characteristicComputational BiologyReproducibility of ResultsGenomicsDNA NeoplasmSequence Analysis DNAMice Inbred C57BLComputational Theory and Mathematics030220 oncology & carcinogenesisModeling and SimulationMutationArtifactsResearch Article
researchProduct

Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology

2020

Inter-patient molecular heterogeneity is the major declared driver of an expanding variety of anticancer drugs and personalizing their prescriptions. Here, we compared interpatient molecular heterogeneities of tumors and repertoires of drugs or their molecular targets currently in use in clinical oncology. We estimated molecular heterogeneity using genomic (whole exome sequencing) and transcriptomic (RNA sequencing) data for 4890 tumors taken from The Cancer Genome Atlas database. For thirteen major cancer types, we compared heterogeneities at the levels of mutations and gene expression with the repertoires of targeted therapeutics and their molecular targets accepted by the current guideli…

Gene mutationMedical OncologychemotherapyGenomeTranscriptomelcsh:ChemistryDrug Delivery SystemsProstateNeoplasmstumor heterogeneityMedicineCluster AnalysisMolecular Targeted TherapyPathology MolecularPrecision Medicinelcsh:QH301-705.5targeted therapeuticscancer drugsSpectroscopyExome sequencingGeneral MedicineGenomicspersonalized medicineComputer Science ApplicationsDrug repositioningmedicine.anatomical_structureAntineoplastic AgentsComputational biologyCatalysisArticleInorganic Chemistrymolecular diagnosticsGenetic HeterogeneityDrug TherapyExome SequencingHumansPhysical and Theoretical ChemistryMolecular Biologygenomeclinical oncologybusiness.industryOrganic ChemistryMolecular diagnosticsmutationslcsh:Biology (General)lcsh:QD1-999MutationPersonalized medicinebusinesstranscriptomeInternational Journal of Molecular Sciences
researchProduct

Interest of exome sequencing trio-like strategy based on pooled parental DNA for diagnosis and translational research in rare diseases.

2021

Abstract Background Exome sequencing (ES) has become the most powerful and cost‐effective molecular tool for deciphering rare diseases with a diagnostic yield approaching 30%–40% in solo‐ES and 50% in trio‐ES. We applied an innovative parental DNA pooling method to reduce the parental sequencing cost while maintaining the diagnostic yield of trio‐ES. Methods We pooled six (Agilent‐CRE‐v2–100X) or five parental DNA (TWIST‐HCE–70X) aiming to detect allelic balance around 8–10% for heterozygous status. The strategies were applied as second‐tier (74 individuals after negative solo‐ES) and first‐tier approaches (324 individuals without previous ES). Results The allelic balance of parental‐pool v…

Genetic MarkersCost effectivenessTranslational researchBiologyQH426-470Sensitivity and SpecificityWorkflowTranslational Research Biomedicalchemistry.chemical_compoundsymbols.namesakeExome SequencingFalse positive paradoxGeneticsHumansDna poolingGenetic Predisposition to DiseaseGenetic TestingAlleleMolecular BiologyGenetics (clinical)Exome sequencingtrio‐like strategy; parental‐pool strategyGeneticsSanger sequencingcost effectivenessReproducibility of Resultsrare diseasesSequence Analysis DNAOriginal ArticleschemistryResearch DesignsymbolsOriginal ArticleDNAGenome-Wide Association StudyMolecular geneticsgenomic medicine
researchProduct

Missense variants in TAF1 and developmental phenotypes: Challenges of determining pathogenicity

2019

We recently described a new neurodevelopmental syndrome (TAF1/MRXS33 intellectual disability syndrome) (MIM# 300966) caused by pathogenic variants involving the X-linked gene TAF1, which participates in RNA polymerase II transcription. The initial study reported eleven families, and the syndrome was defined as presenting early in life with hypotonia, facial dysmorphia, and developmental delay that evolved into intellectual disability (ID) and/or autism spectrum disorder (ASD). We have now identified an additional 27 families through a genotype-first approach. Familial segregation analysis, clinical phenotyping, and bioinformatics were capitalized on to assess potential variant pathogenicity…

Genetics0303 health sciencesHeart malformation030305 genetics & heredityBiologymedicine.diseaseArticleHypotonia03 medical and health sciencesAutism spectrum disorderHuman Phenotype OntologyIntellectual disabilityGeneticsmedicineCopy-number variationAllelemedicine.symptomGenetics (clinical)Exome sequencing030304 developmental biologyHuman Mutation
researchProduct

Abstract LB-382: Identification of predisposing genes for small bowel adenocarcinoma by exome sequencing

2018

Abstract Small bowel adenocarcinoma (SBA) is a rare but aggressive cancer type with limited treatment options. Known predisposing factors include Crohn's disease, celiac disease, and hereditary syndromes such as familial adenomatous polyposis (FAP), Lynch syndrome, and Peutz-Jeghers syndrome. Here, our aim was to further characterize genetic susceptibility to SBA in a large population-based cohort and simultaneously demonstrate the ability to utilize tumor-only data to cost-effectively but reliably call germline variants. Information on all SBAs diagnosed in Finland between the years 2003-2011 were collected utilizing the Finnish Cancer Registry that maintains a nation-wide database on all …

GeneticsCancer ResearchCandidate geneeducation.field_of_studyCancer-Predisposing GenePopulationCancerBiologymedicine.diseaseLynch syndrome3. Good healthFamilial adenomatous polyposisOncologymedicineeducationExomeExome sequencingCancer Research
researchProduct

Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression

2015

The closely related T-box transcription factors TBX2 and TBX3 are frequently overexpressed in melanoma and various types of human cancers, in particular, breast cancer. The overexpression of TBX2 and TBX3 can have several cellular effects, among them suppression of senescence, promotion of epithelial–mesenchymal transition, and invasive cell motility. In contrast, loss of function of TBX3 and most other human T-box genes causes developmental haploinsufficiency syndromes. Stephens and colleagues (1), by exome sequencing of breast tumor samples, identified five different mutations in TBX3, all affecting the DNA-binding T-domain. One in-frame deletion of a single amino acid, p.N212delN, was ob…

GeneticsCancer Researchp21frameshift mutationin-frame deletionMelanomadriver mutationTBX3Biologylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaselcsh:RC254-282Frameshift mutationbreast cancerBreast cancerOncologymedicinesomatic mutationsHaploinsufficiencyGeneTranscription factorLoss functionExome sequencingOriginal ResearchFrontiers in Oncology
researchProduct

A high-throughput genome-wide siRNA screen for ciliogenesis identifies new ciliary functional components and ciliopathy genes.

2015

Defects in primary cilium biogenesis underlie the ciliopathies, a growing group of genetic disorders. We describe the first whole genome siRNA-based reverse genetics screen for defects in biogenesis and/or maintenance of the primary cilium, obtaining a global resource for investigation and interventions into the processes that are critical for the ciliary system. In total, we identified 83 candidate ciliogenesis and ciliopathy genes, including 15 components of the ubiquitin-proteasome system. The validated hits also include 12 encoding G-protein-coupled receptors, and three encoding pre-mRNA processing factors (PRPF6, PRPF8 and PRPF31) mutated in autosomal dominant retinitis pigmentosa. Com…

GeneticsCandidate genePRPF31CiliumCell BiologyBiologymedicine.diseaseCiliopathiesHuman geneticsCiliopathyCiliogenesismedicineOral PresentationExome sequencing
researchProduct

O-115 Parental whole-exome sequencing allows the discovery of genetic causes of extreme IVF phenotypes such as oocyte/embryo developmental arrest and…

2021

Abstract Study question Do whole-exome sequencing (WES) data from infertile women provide valuable information for the discovery of genes/pathways involved in extreme IVF phenotypes, i.e. oocyte/embryo developmental arrest? Summary answer The development of a specific bioinformatic WES pipeline revealed known and new candidate genes/pathways for isolated oocyte/embryo developmental failure,providing the foundation to scale up research. What is known already The use of IVF has made it possible to identify extreme and isolated infertility phenotypes such as recurrent low oocytes maturity (LMR), recurrent low fertilization rate (LFR), or preimplantation developmental arrest (PDA) that would re…

GeneticsInfertilityRehabilitationObstetrics and GynecologyEmbryoBiologyOocytemedicine.diseasePhenotypeHuman fertilizationmedicine.anatomical_structureReproductive MedicinemedicineGeneExome sequencingUnexplained infertilityHuman Reproduction
researchProduct